reglab/housing_qa huggingface dataset:
CO Code § 12-280-202 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 2 - Pharmacy Peer Health Assistance Diversion Program|§ 12-280-202. Definitions

 As used in this part 2, unless the context otherwise requires:    “Impaired practice” means a licensee's inability to meet the requirements of the laws of this state and the rules of the board governing his or her practice when the licensee's cognitive, interpersonal, or psychomotor skills are affected by psychiatric, psychological, or emotional problems; excessive alcohol or drug use; or alcohol or substance use disorders.    “Peer health assistance organization” means an organization that provides a formal, structured program that meets the requirements specified in this part 2 and is administered by appropriate professionals for the purpose of assisting licensees experiencing impaired practice to obtain evaluation, treatment, short-term counseling, monitoring of progress, and ongoing support for the purpose of arresting and treating the licensee's psychiatric, psychological, or emotional problems; excessive alcohol or drug use; or alcohol or substance use disorders.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1485, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-202 as it existed prior to 2019.
CO Code § 12-280-204 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 2 - Pharmacy Peer Health Assistance Diversion Program|§ 12-280-204. Eligibility - Participants

  Any licensee may apply to the board for participation in a qualified peer health assistance program.    In order to be eligible for participation, a licensee shall:   Acknowledge the existence or the potential existence of a psychiatric, psychological, or emotional problem; excessive alcohol or drug use; or a substance use disorder, as defined in section 27-81-102;    After a full explanation of the operation and requirements of the peer health assistance program, agree to voluntarily participate in the program and agree in writing to participate in the program of the peer health assistance organization designated by the board.       Notwithstanding the provisions of this section, the board may summarily suspend the license of any licensee who is referred to a peer health assistance program by the board and who fails to attend or to complete the program. If the board summarily suspends the license, the board shall schedule a hearing on the suspension, which shall be conducted in accordance with section 24-4-105.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1487, § 1, effective October 1. L. 2020: (2)(a) amended,(SB 20-007), ch. 286, p. 1413, § 38, effective July 13. L. 2021: (1), (2)(b), and (3) amended,(SB 21-094), ch. 314, p. 1939, § 23, effective September 1.    Editor's note:   This section is similar to former § 12-42.5-204 as it existed prior to 2019.
CO Code § 12-280-205 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 2 - Pharmacy Peer Health Assistance Diversion Program|§ 12-280-205. Liability

 Nothing in this part 2 creates any liability of the board, members of the board, or the state of Colorado for the actions of the board in making awards to pharmacy peer health assistance organizations or in designating licensees to participate in the programs of pharmacy peer health assistance organizations. No civil action may be brought or maintained against the board, its members, or the state for an injury alleged to have been the result of an act or omission of a licensee participating in or referred to a state-funded program provided by a pharmacy peer health assistance organization. However, the state remains liable under the “Colorado Governmental Immunity Act”, article 10 of title 24, if an injury alleged to have been the result of an act or omission of a licensee participating in or referred to a state-funded peer health assistance program occurred while the licensee was performing duties as an employee of the state.   History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1487, § 1, effective October 1. L. 2021: Entire section amended,(SB 21-094), ch. 314, p. 1939, § 24, effective September 1.    Editor's note:   This section is similar to former § 12-42.5-205 as it existed prior to 2019.
CO Code § 12-280-206 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 2 - Pharmacy Peer Health Assistance Diversion Program|§ 12-280-206. Immunity

 Any member of the board acting pursuant to this part 2 is immune from suit in any civil action under the same conditions for immunity as specified in section 12-20-402 (1) .   History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1488, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-206 as it existed prior to 2019.
CO Code § 12-280-301 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 3 - Wholesalers|§ 12-280-301. Definitions

 As used in this part 3, unless the context otherwise requires:    Repealed.    “Board-registered outlet” means a prescription drug outlet, an other outlet, a nonresident prescription drug outlet, a wholesaler, or a manufacturer.    “Designated representative” means a person authorized by a registered wholesaler to act as a representative for the wholesaler.    Repealed.    “Facility” means a facility of a wholesaler where prescription drugs are stored, handled, repackaged, or offered for sale.    Repealed.    “Pedigree” means a document or electronic file containing information that records each distribution of any given prescription drug in accordance with the DQSA and any federal regulations implementing the DQSA. (7.5) “Prescription drug” has the same meaning as set forth in section 12-280-103 (42) ; except that “prescription drug” excludes any drug specifically exempted under the DQSA and any federal regulations implementing the DQSA.    Repealed.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1488, § 1, effective October 1. L. 2021: (1), (4), (6), and (8) repealed, (3) and (7) amended, and (7.5) added,(SB 21-094), ch. 314, p. 1940, § 25, effective September 1.    Editor's note:   This section is similar to former § 12-42.5-301 as it existed prior to 2019.
CO Code § 12-280-304 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 3 - Wholesalers|§ 12-280-304. Criminal History Record Check

  Prior to submission of an application, each designated representative must have his or her fingerprints taken by a local law enforcement agency or any third party approved by the Colorado bureau of investigation for the purpose of obtaining a fingerprint-based criminal history record check. If an approved third party takes the person's fingerprints, the fingerprints may be electronically captured using Colorado bureau of investigation-approved livescan equipment. Third-party vendors shall not keep the applicant information for more than thirty days unless requested to do so by the applicant. The designated representative shall submit payment by certified check or money order for the fingerprints and for the actual costs of the record check at the time the fingerprints are submitted to the Colorado bureau of investigation. Upon receipt of fingerprints and receipt of the payment for costs, the Colorado bureau of investigation shall conduct a state and national fingerprint-based criminal history record check utilizing records of the Colorado bureau of investigation and the federal bureau of investigation.    When the results of a fingerprint-based criminal history record check of a designated representative performed pursuant to this section reveal a record of arrest without a disposition, the board shall require that designated representative to submit to a name-based criminal history record check, as defined in section 22-2-119.3 (6)(d). The designated representative shall pay the actual costs of the name-based criminal history record check.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1492, § 1, effective October 1; entire section amended,(HB 19-1166), ch. 125, p. 568, § 76, effective October 1.    Editor's note:    This section is similar to former § 12-42.5-304 as it existed prior to 2019.    Before its relocation in 2019, this section was amended in HB 19-1166. Those amendments were superseded by the repeal and reenactment of this title 12, effective October 1, 2019. For those amendments to the former section in effect from April 18, 2019, to October 1, 2019, see HB 19-1166, chapter 125, Session Laws of Colorado 2019.
CO Code § 12-280-305 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 3 - Wholesalers|§ 12-280-305. Restrictions on Transactions

  Repealed.    A manufacturer or wholesaler shall furnish prescription drugs only to a board-registered outlet or practitioner authorized by law to prescribe the drugs. Before furnishing prescription drugs to a person or entity not known to the manufacturer or wholesaler, the manufacturer or wholesaler shall affirmatively verify that the person or entity is legally authorized to receive the prescription drugs by contacting the board.    A manufacturer or wholesaler may furnish prescription drugs to a hospital pharmacy receiving area if a pharmacist or authorized receiving agent signs, at the time of delivery, a receipt showing the type and quantity of the prescription drug received. The pharmacist or authorized receiving agent shall report any discrepancy between the receipt and the type and quantity of the prescription drug actually received to the delivering manufacturer or wholesaler by the next business day after the delivery to the pharmacy receiving area.    Repealed.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1492, § 1, effective October 1. L. 2021: (1) and (4) repealed,(SB 21-094), ch. 314, p. 1942, § 28, effective September 1.    Editor's note:   This section is similar to former § 12-42.5-305 as it existed prior to 2019.   Cross references:   For the “Prescription Drug Marketing Act of 1987”, see Pub.L. 100-293.
CO Code § 12-280-306 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 3 - Wholesalers|§ 12-280-306. Records - Pedigree - Compliance With Dqsa

 A wholesaler shall establish and maintain inventories and records of all transactions regarding the receipt and distribution or other disposition of prescription drugs. The records must include the pedigree for each wholesale distribution of a prescription drug as required pursuant to the DQSA and any federal regulations implementing the DQSA.   History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1493, § 1, effective October 1. L. 2021: Entire section R&RE,(SB 21-094), ch. 314, p. 1943, § 29, effective September 1.    Editor's note:   This section is similar to former § 12-42.5-306 as it existed prior to 2019.
CO Code § 12-280-307 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 3 - Wholesalers|§ 12-280-307. Penalty

  A person who engages in the wholesale distribution of prescription drugs in violation of this part 3 is subject to a penalty of up to fifty thousand dollars.    A person who knowingly engages in the wholesale distribution of prescription drugs in violation of this part 3 is subject to a penalty of up to five hundred thousand dollars.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1494, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-307 as it existed prior to 2019.
CO Code § 12-280-308 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 3 - Wholesalers|§ 12-280-308. Manufacturer, Agent, Representative, or Employee - Drug Cost Information - Required - Definitions

  A manufacturer, or a representative, agent, or employee of a manufacturer, who while employed by or under contract to represent a manufacturer engages in prescription drug marketing, shall provide to a prescriber, in writing, the wholesale acquisition cost of a prescription drug when, in the course of conducting business, the manufacturer, representative, agent, or employee provides information concerning the drug to the prescriber.      When providing the information required by subsection (1) of this section, a manufacturer, or a representative, agent, or employee of a manufacturer, shall also disseminate the names of at least three generic prescription drugs from the same therapeutic class, or if three are not available, as many as are available for prescriptive use.    For the purposes of this section:   “Prescriber” means a health-care provider licensed pursuant to this title 12 who is authorized to prescribe controlled substances or prescription drugs.    “Prescription drug marketing” means any activity that does not include conversations at scientific conferences and that may include in-person meetings, physical mailings, telephonic conversations, video conferencing, electronic mailing or texting, or facsimile transmissions that provides educational or marketing information or materials regarding a prescription drug.    “Therapeutic class” means a group of similar drugs that have the same or similar mechanisms of action and are used to treat a specific condition.            History. Source: L. 2019: Entire section added,(HB 19-1131), ch. 185, p. 2076, § 2, effective October 1.    Editor's note:   This section is similar to § 12-42.5-308 as added in HB 19-1131. That section was superseded by the repeal and reenactment of this title 12, effective October 1, 2019. For the former section in effect from August 2, 2019, to October 1, 2019, see HB 19-1131, chapter 185, Session Laws of Colorado 2019.
CO Code § 12-280-401 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 4 - Electronic Monitoring of Prescription Drugs|§ 12-280-401. Legislative Declaration

  The general assembly finds, determines, and declares that:   Prescription drug misuse occurs in this country to an extent that exceeds or rivals the abuse of illicit drugs;    Prescription drug misuse occurs at times due to the deception of the authorized practitioners where patients seek controlled substances for treatment and the practitioner is unaware of the patient's other medical providers and treatments;    Electronic monitoring of prescriptions for controlled substances provides a mechanism whereby practitioners can discover the extent of each patient's requests for drugs and whether other providers have prescribed similar substances during a similar period of time;    Electronic monitoring of prescriptions for controlled substances provides a mechanism for law enforcement officials and regulatory boards to efficiently investigate practitioner behavior that is potentially harmful to the public.        History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1494, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-401 as it existed prior to 2019.
CO Code § 12-280-402 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 4 - Electronic Monitoring of Prescription Drugs|§ 12-280-402. Definitions

 As used in this part 4, unless the context otherwise requires:    “Controlled substance” means any schedule II, III, IV, or V drug as listed in sections 18-18-204, 18-18-205, 18-18-206, and 18-18-207.    “Drug abuse” or “abuse” means utilization of a controlled substance for nonmedical purposes or in a manner that does not meet generally accepted standards of medical practice.    “Prescription drug outlet” or “pharmacy” means:   Any resident or nonresident pharmacy outlet registered or licensed pursuant to this article 280 where prescriptions are compounded and dispensed; and    Any federally owned and operated pharmacy registered with the federal drug enforcement administration.       “Program” means the electronic prescription drug monitoring program developed or procured by the board in accordance with section 12-280-403.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1495, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-402 as it existed prior to 2019.
CO Code § 12-280-405 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 4 - Electronic Monitoring of Prescription Drugs|§ 12-280-405. Prescription Drug Monitoring Fund - Creation - Fee

  The board may seek and accept money from any public or private entity for the purposes of implementing and maintaining the program. The board shall transmit any money it receives to the state treasurer, who shall credit the money to the prescription drug monitoring fund, which fund is hereby created. The money in the fund is subject to annual appropriation by the general assembly for the sole purpose of implementing and maintaining the program. The money in the fund must not be transferred to or revert to the general fund at the end of any fiscal year.    Repealed.    If, based upon the appropriations for the direct and indirect costs of the program, there is insufficient money to maintain the program, the division may collect an annual fee of no more than seventeen dollars and fifty cents for the fiscal years 2011-12 and 2012-13, twenty dollars for the fiscal years 2013-14 and 2014-15, and twenty-five dollars for each fiscal year thereafter, from an individual who holds a license from the division that authorizes him or her to prescribe a controlled substance, as defined in section 18-18-102 (5). The division shall set the fee pursuant to section 12-20-105 and shall collect the fee in conjunction with the license renewal fees collected pursuant to section 12-20-105. Money collected pursuant to this subsection (3) is credited to the prescription drug monitoring fund created in subsection (1) of this section.    Notwithstanding subsection (1) of this section, on July 1, 2020, the state treasurer shall transfer two hundred sixty-seven thousand five hundred twenty-one dollars from the prescription drug monitoring fund created in subsection (1) of this section to the general fund.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1499, § 1, effective October 1. L. 2020: (4) added,(HB 20-1406), ch. 178, p. 811, § 7, effective June 29. L. 2021: (2) repealed,(SB 21-098), ch. 285, p. 1691, § 3, effective July 1.    Editor's note:   This section is similar to former § 12-42.5-405 as it existed prior to 2019.
CO Code § 12-280-406 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 4 - Electronic Monitoring of Prescription Drugs|§ 12-280-406. Violations - Penalties

 A person who knowingly releases, obtains, or attempts to obtain information from the program in violation of this part 4 shall be punished by a civil fine of not less than one thousand dollars and not more than ten thousand dollars for each violation. Fines paid shall be deposited in the general fund in accordance with section 12-20-404 (6) .   History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1500, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-406 as it existed prior to 2019.
CO Code § 12-280-407 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 4 - Electronic Monitoring of Prescription Drugs|§ 12-280-407. Prescription Drug Outlets - Prescribers - Responsibilities - Liability

  A prescription drug outlet shall submit information in the manner required by the board.    A practitioner who has, in good faith, written a prescription for a controlled substance to a patient is not liable for information submitted to the program. A practitioner or prescription drug outlet who has, in good faith, submitted the required information to the program is not liable for participation in the program.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1500, § 1, effective October 1.    Editor's note:   This section is similar to former § 12-42.5-407 as it existed prior to 2019.
CO Code § 12-280-408 (2021)
2021 Colorado Code|Title 12 - Professions and Occupations|Article 280 - Pharmacists, Pharmacy Businesses, and Pharmaceuticals|Part 4 - Electronic Monitoring of Prescription Drugs|§ 12-280-408. Exemption - Waiver

  A hospital licensed or certified pursuant to section 25-1.5-103, a prescription drug outlet located within the hospital that is dispensing a controlled substance for a chart order or dispensing less than or equal to a twenty-four-hour supply of a controlled substance, and an emergency medical service provider certified or licensed pursuant to section 25-3.5-203 are exempt from the reporting provisions of this part 4. A hospital prescription drug outlet licensed pursuant to section 12-280-114 shall comply with the provisions of this part 4 for controlled substances dispensed for outpatient care that have more than a twenty-four-hour supply.    A prescription drug outlet that does not report controlled substance data to the program due to a lack of electronic automation of the outlet's business may apply to the board for a waiver from the reporting requirements.     History. Source: L. 2019: Entire title R&RE with relocations,(HB 19-1172), ch. 136, p. 1500, § 1, effective October 1; (1) amended,(SB 19-242), ch. 396, p. 3532, § 28, effective October 1.    Editor's note:    This section is similar to former § 12-42.5-408 as it existed prior to 2019.    Before its relocation in 2019, this section was amended in SB 19-242. Those amendments were superseded by the repeal and reenactment of this title 12, effective October 1, 2019. For those amendments to the former section in effect from May 31, 2019, to October 1, 2019, see SB 19-242, chapter 396, Session Laws of Colorado 2019.